Výsledky vyhľadávania - "Gualano, Gina"
-
1
Coinfection of tuberculosis and COVID-19 limits the ability to in vitro respond to SARS-CoV-2
ISSN: 1201-9712, 1878-3511, 1878-3511Vydavateľské údaje: Canada Elsevier Ltd 01.12.2021Vydané v International journal of infectious diseases (01.12.2021)“…•TB and COVID-19 coinfection does not affect M. tuberculosis-specific response.•TB and COVID-19 coinfection limits the ability to in vitro respond to…”
Získať plný text
Journal Article -
2
Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study
ISSN: 1399-3003, 1399-3003Vydavateľské údaje: England 01.05.2017Vydané v The European respiratory journal (01.05.2017)“…Large studies on bedaquiline used to treat multidrug-resistant (MDR-) and extensively drug-resistant tuberculosis (XDR-TB) are lacking. This study aimed to…”
Zistit podrobnosti o prístupe
Journal Article -
3
ERS/ECDC Statement: European Union standards for tuberculosis care, 2017 update
ISSN: 1399-3003, 1399-3003Vydavateľské údaje: England 01.05.2018Vydané v The European respiratory journal (01.05.2018)“…The International Standards for Tuberculosis Care define the essential level of care for managing patients who have or are presumed to have tuberculosis, or…”
Zistit podrobnosti o prístupe
Journal Article -
4
Spike is the most recognized antigen in the whole-blood platform in both acute and convalescent COVID-19 patients
ISSN: 1201-9712, 1878-3511, 1878-3511Vydavateľské údaje: Canada Elsevier Ltd 01.05.2021Vydané v International journal of infectious diseases (01.05.2021)“…•Whole-blood interferon-γ-release assay (IGRA) enabled the response to SARS-CoV-2 peptides to be evaluated.•Spike protein was the best stimulus to discriminate…”
Získať plný text
Journal Article -
5
Characterization of the immune impairment of patients with tuberculosis and COVID-19 coinfection
ISSN: 1201-9712, 1878-3511, 1878-3511Vydavateľské údaje: Canada Elsevier Ltd 01.05.2023Vydané v International journal of infectious diseases (01.05.2023)“…•Tumor necrosis factor-α significantly discriminates tuberculosis (TB)-COVID-19 from COVID-19.•SARS-CoV-2-specific response is significantly impaired in…”
Získať plný text
Journal Article -
6
In-vitro evaluation of the immunomodulatory effects of Baricitinib: Implication for COVID-19 therapy
ISSN: 0163-4453, 1532-2742, 1532-2742Vydavateľské údaje: England Elsevier Ltd 01.04.2021Vydané v The Journal of infection (01.04.2021)“…•Baricitinib has been suggested as a promising therapy for COVID-19.•Baricitinib modulates in vitro SARS-CoV-2-specific-response in a whole blood…”
Získať plný text
Journal Article -
7
Detection of Mycobacterium tuberculosis DNA in CD34+ peripheral blood mononuclear cells of adults with tuberculosis infection and disease
ISSN: 1201-9712, 1878-3511, 1878-3511Vydavateľské údaje: Canada Elsevier Ltd 01.04.2024Vydané v International journal of infectious diseases (01.04.2024)“…•Mycobacterium tuberculosis (Mtb) DNA is detected in the peripheral blood cells of donors with tuberculosis (TB) or TB infection.•Mtb DNA is detected in the…”
Získať plný text
Journal Article -
8
3-Gene-TB-SCORE Accuracy for Tuberculosis Disease Diagnosis Is Not Affected by Immune-Mediated Inflammatory Disease Comorbidity
ISSN: 1422-0067, 1661-6596, 1422-0067Vydavateľské údaje: Switzerland MDPI AG 12.11.2025Vydané v International journal of molecular sciences (12.11.2025)“…Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), remains a major global health threat. Approximately one-quarter of the world’s population has an…”
Získať plný text
Journal Article -
9
New Antituberculosis Drugs: From Clinical Trial to Programmatic Use
ISSN: 2036-7449, 2036-7430, 2036-7449Vydavateľské údaje: Italy MDPI AG 24.06.2016Vydané v Infectious Disease Reports (24.06.2016)“…Treatment of multidrug-resistant tuberculosis (MDR-TB) cases is challenging because it relies on second-line drugs that are less potent and more toxic than…”
Získať plný text
Journal Article -
10
Clinical outcomes and adverse events of nontuberculous mycobacterial lung disease treated at an Italian tertiary referral center
ISSN: 2045-2322, 2045-2322Vydavateľské údaje: London Nature Publishing Group UK 17.11.2025Vydané v Scientific reports (17.11.2025)“…Treatment of NTM lung disease (NTM-LD) is based on combinations of antimycobacterial drugs. It lasts 12 months if respiratory samples become culture negative,…”
Získať plný text
Journal Article -
11
Putting in harm to cure: Drug related adverse events do not affect outcome of patients receiving treatment for multidrug-resistant Tuberculosis. Experience from a tertiary hospital in Italy
ISSN: 1932-6203, 1932-6203Vydavateľské údaje: United States Public Library of Science 28.02.2019Vydané v PloS one (28.02.2019)“…Treatment of multi-drug resistant Tuberculosis (MDR-TB) is challenging because it mostly relies on drugs with lower efficacy and greater toxicity than those…”
Získať plný text
Journal Article -
12
Tuberculin skin test – Outdated or still useful for Latent TB infection screening?
ISSN: 1201-9712, 1878-3511, 1878-3511Vydavateľské údaje: Canada Elsevier Ltd 01.03.2019Vydané v International journal of infectious diseases (01.03.2019)“…•Tuberculin skin test (TST) is over a century old but it continues to be used widely.•When IGRAs were introduced it was anticipated that they would rapidly…”
Získať plný text
Journal Article -
13
Exploratory analysis to identify the best antigen and the best immune biomarkers to study SARS-CoV-2 infection
ISSN: 1479-5876, 1479-5876Vydavateľské údaje: London BioMed Central 26.06.2021Vydané v Journal of translational medicine (26.06.2021)“…Background Recent studies proposed the whole-blood based IFN-γ-release assay to study the antigen-specific SARS-CoV-2 response. Since the early prediction of…”
Získať plný text
Journal Article -
14
Humoral and cellular responses to spike of δ SARS-CoV-2 variant in vaccinated patients with immune-mediated inflammatory diseases
ISSN: 1201-9712, 1878-3511, 1878-3511Vydavateľské údaje: Canada Elsevier Ltd 01.08.2022Vydané v International journal of infectious diseases (01.08.2022)“…•The cellular response to δ SARS-CoV-2 variant is present in vaccinated patients with immune-mediated inflammatory disease (IMID)•The cellular response…”
Získať plný text
Journal Article -
15
Accuracy of QuantiFERON SARS-CoV-2 research use only assay and characterization of the CD4+ and CD8+ T cell-SARS-CoV-2 response: comparison with a homemade interferon-γ release assay
ISSN: 1201-9712, 1878-3511, 1878-3511Vydavateľské údaje: Canada Elsevier Ltd 01.09.2022Vydané v International journal of infectious diseases (01.09.2022)“…•The QuantiFERON SARS-CoV-2 research use only assay response is mediated by CD4+ and CD8+ T cells.•Immune response to the antigen (Ag)2 tube is more accurate…”
Získať plný text
Journal Article -
16
Diagnostic yield of induced sputum and Bronchoalveolar lavage in suspected pulmonary tuberculosis
ISSN: 1471-2334, 1471-2334Vydavateľské údaje: London BioMed Central 08.05.2025Vydané v BMC infectious diseases (08.05.2025)“…Aim of this study was to compare the diagnostic yield of induced sputum (IS) and bronchoalveolar lavage (BAL) in patients with suspected pulmonary tuberculosis…”
Získať plný text
Journal Article -
17
Treatment Outcomes in Multidrug-Resistant Tuberculosis
ISSN: 0028-4793, 1533-4406, 1533-4406Vydavateľské údaje: United States Massachusetts Medical Society 15.09.2016Vydané v The New England journal of medicine (15.09.2016)“…Multidrug-resistant tuberculosis is a major global challenge. This report examines the definition of treatment success and its effect on determining cure. To…”
Získať plný text
Journal Article -
18
Concurrent cavitary pulmonary tuberculosis and COVID-19 pneumonia with in vitro immune cell anergy
ISSN: 0300-8126, 1439-0973, 1439-0973Vydavateľské údaje: Berlin/Heidelberg Springer Berlin Heidelberg 01.10.2021Vydané v Infection (01.10.2021)“…Tuberculosis (TB) is top infectious disease killer caused by a single organism responsible for 1.5 million deaths in 2018. Both COVID-19 and the pandemic…”
Získať plný text
Journal Article -
19
Increase in Tuberculosis Diagnostic Delay during First Wave of the COVID-19 Pandemic: Data from an Italian Infectious Disease Referral Hospital
ISSN: 2079-6382, 2079-6382Vydavateľské údaje: Switzerland MDPI AG 08.03.2021Vydané v Antibiotics (Basel) (08.03.2021)“…Background: The WHO advised that the impact of COVID-19 pandemic on TB services was estimated to be dramatic due to the disruption of TB services. Methods: A…”
Získať plný text
Journal Article -
20
Immunomodulatory effects of cysteamine and its potential use as a host-directed therapy for tuberculosis
ISSN: 1664-3224, 1664-3224Vydavateľské údaje: Switzerland Frontiers Media SA 28.10.2024Vydané v Frontiers in immunology (28.10.2024)“…Cysteamine, a drug approved to treat cystinosis, has been proposed as a host-directed therapy for (Mtb) and SARS-CoV-2. The impact of cysteamine on the immune…”
Získať plný text
Journal Article